Cargando…
Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke
Aims: Clopidogrel is an antiplatelet drug primarily used to treat or prevent acute ischemic stroke (IS) or myocardial infarction (MI). This prodrug requires biotransformation to an active metabolite by cytochrome P450 (CYP) enzymes, and CYP single nucleotide polymorphisms (SNPs) could affect the eff...
Autores principales: | Yi, Xingyang, Lin, Jing, Wang, Yanfen, Zhou, Qiang, Wang, Chun, Cheng, Wen, Chi, Lifen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098919/ https://www.ncbi.nlm.nih.gov/pubmed/26961113 http://dx.doi.org/10.5551/jat.33290 |
Ejemplares similares
-
Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke
por: Yi, Xingyang, et al.
Publicado: (2018) -
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
por: Yi, Xingyang, et al.
Publicado: (2020) -
The secondary prevention of stroke according to cytochrome P450 2C19 genotype in patients with acute large-artery atherosclerosis stroke
por: Yi, Xingyang, et al.
Publicado: (2018) -
Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population
por: Yi, Xingyang, et al.
Publicado: (2017) -
Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping
por: Han, Sang Won, et al.
Publicado: (2017)